Rituximab in combination with CHOP improves survival in elderly patients with aggressive non-Hodgkin's lymphoma

被引：7
|
作者：
Coiffier, B [1 ]
机构：
[1] Ctr Hosp Lyon Sud, Hematol Serv, Lyon, France
来源：
TUMORI | 2002年 / 88卷 / 01期
关键词：
D O I：
10.1177/030089160208800108
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S26 / S28
页数：3
相关论文
共 50 条
  • [41] Sphingosomal vincristine in chop ± rituximab:: A promising new treatment for patients with high risk untreated aggressive non-Hodgkin's lymphoma (NHL)
    Rodriguez, M
    Sarris, A
    Dang, N
    ANNALS OF ONCOLOGY, 2005, 16 : 209 - 209
  • [42] Prospective randomized study comparing MEMID with a chop-like regimen in elderly patients with aggressive non-Hodgkin's lymphoma
    Chamorey, E
    Gressin, R
    Peyrade, F
    Rossi, JF
    Lepeu, G
    Foussard, C
    Harrousseau, JL
    Fabbro, M
    Richard, B
    Delwail, V
    Maisonneuve, H
    Vilque, JP
    Thyss, A
    ONCOLOGY, 2005, 69 (01) : 19 - 26
  • [43] Is There a Benefit of Adding Rituximab to CHOP in the Overall Survival of Patients with B-Cell Non-Hodgkin's Lymphoma in a Developing Country ?
    Ruiz-Delgado, Guillermo J.
    Gomez Almaguer, David
    Tarin-Arzaga, Luz C.
    Cantu-Rodriguez, Olga
    Alarcon-Urdaneta, Carlos
    Rodriguez-Morales, Uxmal
    Calderon-Garcia, Jackeline
    Fernandez-Vargas, Omar
    Montes-Montiel, Maryel
    Sanchez-Cardenas, Monica
    Ruiz-Arguelles, Guillermo J.
    BLOOD, 2012, 120 (21)
  • [44] Is there a benefit to adding rituximab to CHOP in the overall survival of patients with B-cell non-Hodgkin's lymphoma in a developing country?
    Ruiz-Delgado, Guillermo J.
    Gomez-Almaguer, David
    Tarin-Arzaga, Luz C.
    Cantu-Rodriguez, Olga G.
    Alarcon Urdaneta, Carlos
    Rodriguez-Morales, Uxmal
    Calderon-Garcia, Jackeline
    Fernandez-Vargas, Omar
    Montes-Montiel, Maryel
    Sanchez-Cardenas, Nica
    Ruiz-Argueelles, Guillermo J.
    HEMATOLOGY, 2012, 17 (04) : 193 - 197
  • [45] Rituximab monotherapy is effective in patients with poor risk refractory aggressive non-Hodgkin's lymphoma
    Rothe, A
    Schulz, H
    Elter, T
    Engert, A
    Reiser, M
    HAEMATOLOGICA, 2004, 89 (07) : 875 - 876
  • [46] Adapted CHOP plus rituximab in non-Hodgkin's lymphoma in patients over 80 years old
    Italiano, Antoine
    Jardin, Fabrice
    Peyrade, Frederic
    Saudes, Laurence
    Tilly, Herve
    Thyss, Antoine
    HAEMATOLOGICA, 2005, 90 (09) : 1281 - +
  • [47] Cost analysis of hospitalization for CHOP-rituximab therapy in patients with non-Hodgkin's lymphoma (NHL).
    Bonfort, P
    Queuille, E
    Camilleri, M
    Hequet, O
    Thieblemont, C
    Bureau, J
    Bouafia, F
    Coiffier, B
    Dumontet, C
    BLOOD, 2002, 100 (11) : 292B - 292B
  • [48] Long term follow-up of a phase II study of Rituximab in combination with CHOP chemotherapy in patients with previously untreated aggressive non-Hodgkin's lymphoma (NHL).
    Vose, JM
    Link, BK
    Grossbard, ML
    Czuczman, M
    Grillo-Lopez, A
    Benyunes, M
    Gaynor, E
    Fisher, RI
    BLOOD, 2002, 100 (11) : 361A - 361A
  • [49] Monoclonal antibody improves survival in non-Hodgkin's lymphoma
    不详
    BIOTECHNOLOGY LAW REPORT, 2002, 21 (04) : 339 - 340
  • [50] CHOP chemotherapy with rituximab in DLBCL non-Hodgkin's lymphoma (NHL) - Our experience
    Utracka-Hutka, B
    Cedrych, I
    Polakiewicz-Gilowska, A
    Szelc, S
    ANNALS OF ONCOLOGY, 2005, 16 : 178 - 178
12345